73% of Healthcare Sites Run Ad Trackers That Ignore Opt-Outs

Bypaulgruensfelder
Piwik PRO July 6, 2026
Read Full Article →
AI-Generated Summary

73% of 59 major U.S. hospital and clinic websites were running advertising or marketing trackers even when visitors sent an active Global Privacy Control opt-out signal, according to an independent audit conducted by Verified Data for Piwik PRO. Sixty-nine percent used marketing or advertising cookies, and the narrow gap between the two figures indicates some trackers operate without cookies — meaning cookie-blocking alone does not close the exposure. Scans detected 75 unique tracking tools across the sites, including Google Marketing Platform on 33 domains and Google Analytics on 20. Cumulative healthcare pixel enforcement actions and settlements have exceeded $100 million since 2023.

Why It Matters

Marketing leaders at multi-site groups are carrying legal exposure they usually cannot see from inside the ad platform. The practical fix is infrastructure, not policy — enforce opt-out at the tag layer, pull ad pixels off condition and appointment pages, and make BAA availability a hard requirement in vendor selection.

hipaa marketing compliance pixel tracking global privacy control healthcare analytics server-side tracking marketing attribution patient data privacy

This article appears to be vendor-created or sponsored content. While we appreciate the value of the underlying information, our inclusion of it does not constitute an endorsement of the company itself.

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

Do healthcare websites still run ad trackers after a visitor opts out?

In most cases tested, yes. An audit of 59 major U.S. hospital and clinic sites found 73% still had advertising or marketing trackers firing while an active Global Privacy Control signal was present. GPC is a legally recognized opt-out in California and 11 other states, which makes ignoring it at the tag layer difficult to characterize as an accidental misconfiguration.

Can Google Analytics be made HIPAA-compliant?

No. Google does not sign business associate agreements and explicitly prohibits HIPAA-covered entities from using its services for any purpose involving PHI. Data also flows through Google’s infrastructure under Google’s terms. Adobe Analytics offers BAA arrangements, but only for certain enterprise configurations — the standard implementation does not provide a compliant path.

What counts as PHI on a healthcare marketing website?

More than most marketing teams assume. IP addresses combined with visits to condition-specific pages, URL paths that reveal a service line or physician profile, form-field data captured before submission, behavior inside patient portals, and click IDs such as GCLID or FBCLID that tie health-related actions back to an advertising profile can all qualify.

Similar Posts

  • Optimizely Enters the AEO Race With Agent Visibility Analytics

    Bypaulgruensfelder

    Optimizely launched a full Answer Engine Optimization (AEO) platform on June 10, 2026, introducing Agent Visibility Analytics and a new data-sharing partnership with Conductor. Built inside Optimizely Analytics, the tool uses log-level data, not modeled estimates, to show which AI agents and crawlers are accessing a site’s content, classified by intent and broken out by funnel stage or topic area. The launch pairs that visibility layer with two autonomous agents: one that flags content gaps versus competitors in AI search results, and one that benchmarks AI-driven share of voice. The release follows similar AEO moves from Siteimprove, HubSpot, Webflow, and Sitecore, as Google’s AI Mode surpasses 1 billion monthly active users.

  • CMS Proposes 2027 Physician Payment Overhaul: MIPS Sunset and ACO Expansion

    Bypaulgruensfelder

    CMS’s proposed CY 2027 Physician Fee Schedule rule would sunset traditional MIPS reporting in 2029, replace it with specialty-focused MIPS Value Pathways covering roughly 98% of specialties, and make Medicare ACOs easier to join and more rewarding. The Medicare Shared Savings Program — which paid $4.1 billion in shared savings to 75% of its 476 ACOs for 2024 while generating about $2.5 billion in net Medicare savings — would gain new-entrant financial incentives, more predictable spending benchmarks, and the option to reduce beneficiary cost-sharing starting April 2027. CMS also proposes recalibrating physician payment rates, introducing MIPS Core Measures in 2027, and closing an APM incentive loophole worth an estimated $2.38 billion over a decade.

  • The Attribution Problem Your Board Doesn’t Understand

    Bypaulgruensfelder

    Healthcare marketing attribution is genuinely hard for multi-site groups because patient journeys are long, largely offline, and privacy-constrained—and a budget you can’t defend is a budget that gets cut. Strategy Collective’s Matt Lee argues perfect attribution doesn’t exist, but ‘good enough’ attribution is achievable through four moves: call tracking, redesigned patient intake questions, a blended market-level report, and separating brand demand from generated demand. The bigger fix is reframing the board conversation itself. Instead of asking ‘is marketing working?’, leaders should ask ‘how do we make Market B look like Market A?’—shifting from an unwinnable ROI-proof debate to a comparative, market-level view that drives real reallocation decisions.

  • Q3 2026 AI Trends: What Growth Leaders Need to Track

    Bypaulgruensfelder

    The most useful AI question for growth-stage leaders in Q3 2026 has shifted from what models can do to what results they actually deliver. Summit Partners’ AI and data science team flags five developments to track: the conversation has moved from capability to production results; the binding constraint is rarely the model itself but data, workflow, and integration; agents are evolving from assistants to actors, with trust as the real limiting factor; the underlying economics of AI are being rewritten; and leaders must separate genuine signal from noise while recognizing what work stays human. The throughline is disciplined execution—turning promising pilots into dependable, measurable production systems.

  • PE’s Quieter Playbook: Joint Ventures With Nonprofit Health Systems

    Bypaulgruensfelder

    Private equity firms are increasingly expanding in healthcare through joint ventures with nonprofit health systems rather than outright buyouts, according to a new report from the Private Equity Stakeholder Project. The report finds 21.4% of private equity-owned hospitals are held through joint venture arrangements with nonprofit systems, and the structure now spans hospitals, inpatient rehab, hospice, home health, behavioral health, ambulatory surgery centers and urgent care — likely an undercount, since the tally covers only publicly identifiable arrangements. Case studies include ventures involving Lifepoint Health, Compassus, Ardent Health Services and Ascension. PESP argues these JVs have drawn far less scrutiny than traditional PE buyouts even as they become more common, prompting calls for greater oversight.

  • Why Penn Medicine Is Deploying AI Agents for Patient Intake

    Bypaulgruensfelder

    Penn Medicine is integrating K Health’s AI-powered patient intake agents into its virtual primary care service, testing whether an AI ‘team member’ in the patient-provider relationship improves outcomes. The agents collect symptoms and medical history before a visit and convert them into structured summaries that feed directly into the clinician’s existing workflow — providers start appointments already informed, and patients get routed to the right level of care. The same K Health technology already runs inside virtual care programs at Cedars-Sinai, Mayo Clinic, Mass General Brigham and Hartford HealthCare, with use cases ranging from new-patient acquisition to expanding primary care access. If the pilot succeeds, Penn plans to extend the agents into in-person primary care offices and specialty clinics.